Trial Details

Not Recruiting
Basic Information
Clinical ID c4972
Identifier ISRCTN81965907
Trial Title The value of faecal calprotectin (CPT) in monitoring the response to treatment of patients with inflammatory bowel disease
Trial URL Visit Original Page
Study Information
Study Results

NULL

Conditions Inflammatory bowel disease Digestive System Crohn's disease [regional enteritis]
Interventions Patients with active inflammatory bowel disease will be treated for 2 weeks according to the advice of their clinicians with either oral prednisolone 40 mg daily (ulcerative colitis or Crohn's) or enteral feeds (Crohn's disease only). Patients failing to
Participant Information
Sponsor Department of Health (UK)
City NULL
Country/Region United Kingdom
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement NULL
Study Design
Study Type Interventional
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL